Abstract
The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.
Author supplied keywords
Cite
CITATION STYLE
APA
Grant, J. S., & Graven, L. J. (2016). Progressing from Metformin to Sulfonylureas or Meglitinides. Workplace Health and Safety, 64(9), 433–439. https://doi.org/10.1177/2165079916644263
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free